Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

Analysis summary4-Traders Strategies

Anaïs Lozach

share with twitter share with LinkedIn share with facebook
share via e-mail

Expect the comeback of a strong trend

Strategy published on 05/10/2017 | 14:51
long trade
Target price hit
Entry price : 122.91$ | Target : 128$ | Stop-loss : 120.95$ | Potential : 4.14%
Johnson & Johnson shares stand out with an interesting technical chart pattern displaying horizontal consolidation. One would assume that the current accumulation phase will cede eventually to an acceleration to the upside.
Investors have an opportunity to buy the stock and target the $ 128.
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.

  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Sales forecast by analysts have been recently revised upwards.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 119.32 USD

  • The company's "enterprise value to sales" ratio is among the highest in the world.
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials ($)
Sales 2017 76 224 M
EBIT 2017 23 484 M
Net income 2017 15 953 M
Debt 2017 16 378 M
Yield 2017 2,38%
P/E ratio 2017 24,13
P/E ratio 2018 19,71
EV / Sales 2017 5,17x
EV / Sales 2018 4,79x
Capitalization 378 B
Surperformance© ratings
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Earnings quality
Business Predictability
P/E ratio
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
Bollinger Spread
Unusual Volumes
Duration : Period : Day
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Duration : Period : Week
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders